| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/14/2004 | EP1379138A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | CN1468235A Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468215A 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1134447C Cefixime tert-octyl ammonium salts , process for preparing the same and method for purification of cefixime |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/14/2004 | CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine |
| 01/13/2004 | US6677457 Halogenation |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 01/13/2004 | US6677277 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides |
| 01/13/2004 | CA2049162C Ortho-substituted phenylacetamides |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2004002481A1 Aryl carbonyl derivatives as therapeutic agents |
| 01/08/2004 | WO2004002480A1 Novel glucagon antagonists/inverse agonists |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006224 Synthesis of 2-alkyl amino acids |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040006115 2-Oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 01/08/2004 | US20040006112 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 01/08/2004 | US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis |
| 01/08/2004 | US20040006076 Thiazolyl amide derivatives |
| 01/08/2004 | US20040006058 As inhibitors of cyclin-dependent kinase 4 (Cdk4); antiproliferative agents; for therapy of cancer, tumors |
| 01/08/2004 | CA2744893A1 Aryl carbonyl derivatives as glucokinase activators |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377278A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv |
| 01/07/2004 | CN1466584A Tetrazolyl-phenyl acetamide glucokinase activators |
| 01/07/2004 | CN1466582A Substituted aryl ketones and their use as herbicides |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1133627C Intermediate of N-benzyl dioxothiazolidinyl benzoyl amide derivatives, and its prepn. method |
| 01/06/2004 | US6673927 Farnesyl transferase inhibitors |
| 01/06/2004 | US6673821 Nitrogen heterocycle inhibitors of aspartyl protease |
| 01/06/2004 | US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/06/2004 | US6673816 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | US6673772 Dipeptide compounds and their use as antiviral agents |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1140819B1 Alfa-sulfenimino acid derivatives |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002506 Antiproliferative agents; antitumor agents |
| 01/01/2004 | US20040002485 Enzyme inhibitors; viricides |
| 01/01/2004 | US20040001970 Organic electroluminescent materials and devices made from such materials |
| 12/31/2003 | WO2004001059A2 Heterocyclic inhibitors of kinases |
| 12/31/2003 | WO2004000822A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators |
| 12/31/2003 | WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | WO2004000215A2 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 12/31/2003 | WO2003063576A3 Arylsulfonamidobenzylic compounds |
| 12/31/2003 | CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 12/31/2003 | CN1132823C Prepn. of 2-aminothiazole derivative hydrobromate-2-isomer |
| 12/31/2003 | CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals |
| 12/31/2003 | CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 12/25/2003 | US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester |
| 12/25/2003 | US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine |
| 12/25/2003 | US20030236426 Synthesis of benzimidate from benzoic acid |
| 12/25/2003 | US20030236417 A 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid or ester derivatives, use as iron metabolic chelators in therapeutic applications; demetallization |
| 12/25/2003 | US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236391 Imaging amyloid deposits in living patients, with an amyloid binding agents having radiolabeled iodine; radiotherapy |
| 12/25/2003 | US20030236289 Antiinflammatory agents; analgesics; antipyretics; cyclooxygenase inhibitor |
| 12/25/2003 | US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents |
| 12/25/2003 | US20030236274 Naphthalene derivatives, their production and use |
| 12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 12/25/2003 | US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease |
| 12/25/2003 | US20030236227 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 12/24/2003 | WO2003106456A2 New compounds |
| 12/24/2003 | WO2003106442A1 Process for preparing thiazole derivative and the intermediate compounds for preparing the same |
| 12/24/2003 | WO2003106439A1 Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation |
| 12/24/2003 | WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid |